Upcoming

Influx Healthtech Limited IPO

Influx Healthtech Limited is a health technology company focused on providing innovative, scalable, and accessible healthcare solutions across diagnostics, preventive care, and digital health management. The company leverages a combination of clinical expertise, technology platforms, and data analytics to deliver health services that cater to both individual consumers and institutional clients.

RHP DRHP

Min Investment

₹1,15,200

Lot Size

1,200 Shares

Price Range

₹96.0

Issue Size (₹ Cr.)

₹58.57

IPO Type

NSE SME

Key Metrics

Face Value

₹ 10

GMP

₹ 40.0

Subscription

EPS

₹ 5.77

P/E Ratio

16.63 x

RoNW

36.98%

ROE

36.98%

Debt to Equity (₹ Cr.)

0.01

Timeline

IPO Open18/06/2025Wednesday

IPO Close20/06/2025Friday

Allotment23/06/2025Monday

Refund24/06/2025Tuesday

Listing25/06/2025Wednesday

Strengths

Integrated Healthtech Model Influx Healthtech operates across diagnostics, preventive healthcare, and digital health, giving it a diversified revenue base and multiple touchpoints with patients and partners.
Strong Technology Backbone The company’s proprietary digital platform enables online test booking, report access, health monitoring, and teleconsultations—offering convenience and scalability in both urban and semi-urban markets.
Wide Network of Diagnostic Centers A growing network of collection centers and partner labs strengthens its physical presence and supports fast turnaround times for test results.
Focus on Preventive and Wellness Care By offering corporate wellness programs and preventive health packages, the company taps into a high-margin, underpenetrated segment of the healthcare industry.
Experienced Management and Medical Team Led by professionals with deep experience in healthcare, diagnostics, and technology, the company is well-positioned to navigate regulatory, operational, and digital transitions in the sector.

Weaknesses

Limited Brand Recognition Compared to Larger Players The company operates in a competitive diagnostic and digital health space dominated by established national chains, which may limit its visibility in new markets.
Dependence on Partner Labs and Third-Party Infrastructure While the asset-light model supports scalability, reliance on partner labs can affect quality control and operational consistency across regions.
Regulatory and Compliance Sensitivity As a healthcare service provider, the company must adhere to evolving healthcare regulations, data privacy norms, and quality standards, which may increase operational complexity and costs.
Geographic Concentration Risk A significant portion of revenue may be concentrated in a few regions, making it vulnerable to local disruptions, policy changes, or competitive pressures.
Technology Adoption Barrier in Rural Areas Although digital health platforms offer scalability, limited digital literacy and internet penetration in rural areas could slow down adoption and impact customer acquisition.